The Clinical Development team at ShouTi is responsible for designing, overseeing, and executing clinical trials focused on GPCR-targeted therapies. They ensure compliance with regulatory standards, manage operational aspects of clinical studies, and collaborate with pharmacology experts to optimize drug development outcomes. This team plays a critical role in advancing innovative treatments in the cardiopulmonary space from concept to market.